Cargando…
2765. Dalbavancin for challenging left ventricular assist device driveline infections
BACKGROUND: Driveline tract and exit site infections (DLI) in patients on left ventricular assist device (LVAD) support occur frequently and are associated with significant morbidity, mortality and recurrence. Dalbavancin is a gram+ active lipoglycopeptide antibiotic with a prolonged half-life. Give...
Autores principales: | Doligalski, Christina, Lachiewicz, Anne, Friedland, Anne, Snider, Cynthia, Bowen, Amanda, Marx, Ashley H, Byku, Mirnela, Bartelt, Luther A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676933/ http://dx.doi.org/10.1093/ofid/ofad500.2376 |
Ejemplares similares
-
Left ventricular assist device driveline infections in three contemporary devices
por: Schlöglhofer, Thomas, et al.
Publicado: (2020) -
Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests
por: Kranzl, Melanie, et al.
Publicado: (2021) -
Bowel obstruction due to retained intraperitoneal left ventricular assist device (LVAD) driveline
por: Miklin, Daniel, et al.
Publicado: (2018) -
Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients
por: Köhler, Ann‐Kristin, et al.
Publicado: (2022) -
1540. Left Ventricular Assist Device Driveline Infections: Relapsed Infections and Minimum Inhibitory Concentration Changes
por: Lines, Tara, et al.
Publicado: (2018)